Thu, Aug 15, 2024 2:00 PM – 3:00 PM EDT Presenter: Carl Marci, MD, Chief Clinical Officer and Chief Psychiatrist and Managing Director of Mental Health and Neuroscience, OM1 Register >> Treatment-resistant depression (TRD) presents a formidable challenge for life sciences researchers, with its complex definition varying across clinical care, reimbursement, and regulatory contexts. This[…]
DATE: Thursday, May 23, 2024 TIME: 11:00 am EST PRESENTER: Joseph Zabinski, PhD REGISTER HERE >> In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum. Real-world data provide insight into[…]
Thu, Mar 28, 2024 2:00 PM – 3:00 PM EDT Presenters: Sonja Wustrack, MPH, Managing Director, Integrated Evidence Generation and Michelle Leavy, MPH Director, Real-World Evidence Strategy Register >> Integrated evidence generation is gaining traction in the biopharmaceutical industry as an approach to aligning evidence needs across functions within a company. Real-world data and real-world[…]
Wed, Jan 31, 2024 2:00 PM – 3:00 PM EST Register here >> With the new year comes even more hype with how AI will transform the healthcare and pharmaceutical landscape – including McKinsey estimating that AI technology could generate up to $110 billion a year in economic value for the pharma and medical-product industries.[…]
MAPS Webinar 9/15/23 Listen to the full webianr >> Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.
